Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Dreyling(Ludwig-Maximilians-Universität München), Marco Ladetto(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Umberto Vitolo(Candiolo Cancer Institute), Michele Ghielmini(Institute of Oncology Research), Simon Rule(AstraZeneca (United Kingdom)), Gilles Salles(Memorial Sloan Kettering Cancer Center)
Cited by 228
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|920
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2017|736
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
|Advances in Therapy|2017|603